Everest Medicines Partners with Corxel to Introduce CARDAMYST™ Nasal Spray in Greater China

March 23, 2026

Everest Medicines has signed a key agreement with Corxel to launch the innovative CARDAMYST™ nasal spray across Greater China. This venture marks a significant move that aims to revolutionize treatment.....

Subscribe for Full Access!

Gain valuable retail and trade intelligence from our database of millions of data points spanning 20+ years!

Subscribe!

Key Data Topics CARDAMYST, cardiovascular care, China, clinical trials, collaboration, Corxel, Everest Medicines, medical innovation, NMPA approval, patient care, therapy development

Share this Data

Other Retail Intelligence

Higher-end Retail Trends in Hong Kong Attract Well-Heeled Tourists

March 23, 2026

The Evolving Landscape of China's Emotional Economy

March 23, 2026

Shifting Trends in Hong Kong Retail: Ground-Floor Resurgence Signals Market Adjustment

March 22, 2026

Chinese Automaker Set to Shake Up Industry With Punitive Measures Against Traditional Competitors

March 22, 2026

Bank of Ningbo in Final Stages of Launching Digital Yuan Platform Amid China's Growing E-CNY Expansion

March 20, 2026

Apple Sees Impressive Rise in China Smartphone Sales Despite Declining Market

March 20, 2026